Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow, India.
Nanomedicine. 2012 May;8(4):468-77. doi: 10.1016/j.nano.2011.07.002. Epub 2011 Jul 23.
In this study the potential of 2 different ligands, i.e., palmitoyl mannose (Man-Lip) and 4-SO(4)GalNAc (Sulf-Lip) to target resident macrophages was investigated after surface decoration of Amphotericin B (AmB) loaded liposomes. In the case of Sulf-Lip, the 4-SO(4)GalNAc was adsorbed through electrostatic interaction on cationic liposomes, which was confirmed by change in zeta potential from +48.2 ± 3.7 mV for Lip to +12.2 ± 1.3 mV for Sulf-Lip. The mean particle size of Sulf-Lip and Man-Lip was found to be 139.4 ± 7.4 nm and 147.4 ± 8.6 nm, respectively. Flow cytometric data reveal enhanced uptake of Sulf-Lip in both J774 and RAW cell lines in comparison with the uptake of Man-Lip. Intracellular localization studies indicate that the fluorescence intensity of Sulf-Lip was much higher in comparison with that of Man-Lip and Lip formulations. Sulf-Lip and Man-Lip showed significantly higher localization of AmB at all time points in comparison with Lip (P < 0.05) after intravenous (IV) administration. The studies provide evidence that 4-SO(4)GalNAc possesses a promising feature for targeting resident macrophages and its application in the conditions of leishmaniasis is in the offing.
This in vivo study compares two different ligands to deliver Amphotericin B l(AmB) loaded liposomes to resident macrophages. Targeted approaches showed significantly higher localization of AmB at all time points in comparison to non-targeted liposomes, and future applications in leishmaniasis are already under preparation.
在这项研究中,研究了两种不同配体,即棕榈酰甘露糖(Man-Lip)和 4-SO(4)GalNAc(Sulf-Lip),在阿霉素(AmB)负载脂质体表面修饰后,将其靶向驻留巨噬细胞的潜力。在 Sulf-Lip 的情况下,4-SO(4)GalNAc 通过静电相互作用吸附在阳离子脂质体上,这从脂质体的 ζ 电位从+48.2±3.7 mV 变为+12.2±1.3 mV 得到证实。Sulf-Lip 和 Man-Lip 的平均粒径分别为 139.4±7.4nm 和 147.4±8.6nm。流式细胞术数据显示,与 Man-Lip 相比,Sulf-Lip 在 J774 和 RAW 细胞系中的摄取量增加。细胞内定位研究表明,与 Man-Lip 和 Lip 制剂相比,Sulf-Lip 的荧光强度要高得多。与 Lip 相比,Sulf-Lip 和 Man-Lip 在静脉注射(IV)给药后所有时间点的 AmB 定位明显更高(P<0.05)。这些研究表明,4-SO(4)GalNAc 具有靶向驻留巨噬细胞的有前途的特征,并且它在利什曼病的应用即将到来。
本体内研究比较了两种不同的配体,将阿霉素(AmB)负载的脂质体递送至驻留巨噬细胞。与非靶向脂质体相比,靶向方法在所有时间点均显示出更高的 AmB 定位,并且已经在准备将其应用于利什曼病。